Site Map - Soleno

Company
- Management
- Board
- Advisors
- Careers
Product Candidate
For Patients
- Prader-Willi Syndrome
- Patient Access
Investors
Contact us

Pages

Advisors
Boards
Careers
Clinical References form
Clinical Studies forms
Clinical Trials
Company
Completed Studies
Contact us
DCCR
Home Page
MODE OF ACTION
Patient Access
PRADER-WILLI SYNDROME
Privacy Statement
Site Map
Terms of Use

Developing novel therapeutics for the treatment of rare diseases.

Pages

Company
- Management
- Boards
- Advisors
- Careers
For Patients
- Prader-Willi Syndrome
Investors
Contact us

News and Events

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

Soleno Therapeutics Announces Financing Commitment for up to $60 Million

Contact Us

203 Redwood Shores Parkway
Suite 500
Redwood City, CA 94065

Tel: (650) 213-8444
Email: info@soleno.life
Find us on Facebook

Soleno Therapeutics, Inc. © 2023 | All Rights Reserved

Terms of Use
Privacy Statement